TY - CHAP
T1 - Modeling the Blood-Brain Barrier Using Human-Induced Pluripotent Stem Cells
AU - Mesentier-Louro, Louise A.
AU - Suhy, Natalie
AU - Broekaart, Diede
AU - Bula, Michael
AU - Pereira, Ana C.
AU - Blanchard, Joel W.
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - The blood-brain barrier (BBB) is a key physiological component of the brain, protecting the brain from peripheral processes and pathogens. The BBB is a dynamic structure that is heavily involved in cerebral blood flow, angiogenesis, and other neural functions. However, the BBB also creates a challenging barrier for the entry of therapeutics into the brain, blocking more than 98% of drugs from contact with the brain. Neurovascular comorbidities are common in several neurological diseases including Alzheimer’s and Parkinson’s Disease, suggesting that BBB dysfunction or break down likely has a causal role in neurodegeneration. However, the mechanisms by which the human BBB is formed, maintained, and degenerated in diseases remain largely unknown due to limited access to human BBB tissue. To address these limitations, we have developed an in vitro induced human BBB (iBBB) derived from pluripotent stem cells. The iBBB model can be used for discovery of disease mechanisms, drug targets, drug screening, and medicinal chemistry studies to optimize brain penetration of central nervous system therapeutics. In this chapter, we will explain the steps to differentiate the three cellular components (endothelial cells, pericytes, and astrocytes) from induced pluripotent stem cells, and how to assemble them into the iBBB.
AB - The blood-brain barrier (BBB) is a key physiological component of the brain, protecting the brain from peripheral processes and pathogens. The BBB is a dynamic structure that is heavily involved in cerebral blood flow, angiogenesis, and other neural functions. However, the BBB also creates a challenging barrier for the entry of therapeutics into the brain, blocking more than 98% of drugs from contact with the brain. Neurovascular comorbidities are common in several neurological diseases including Alzheimer’s and Parkinson’s Disease, suggesting that BBB dysfunction or break down likely has a causal role in neurodegeneration. However, the mechanisms by which the human BBB is formed, maintained, and degenerated in diseases remain largely unknown due to limited access to human BBB tissue. To address these limitations, we have developed an in vitro induced human BBB (iBBB) derived from pluripotent stem cells. The iBBB model can be used for discovery of disease mechanisms, drug targets, drug screening, and medicinal chemistry studies to optimize brain penetration of central nervous system therapeutics. In this chapter, we will explain the steps to differentiate the three cellular components (endothelial cells, pericytes, and astrocytes) from induced pluripotent stem cells, and how to assemble them into the iBBB.
KW - Blood-brain barrier
KW - Endothelial cells
KW - Induced pluripotent stem cells
KW - Permeability
KW - Transwell
KW - Vascularization
UR - http://www.scopus.com/inward/record.url?scp=85163613679&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-3287-1_11
DO - 10.1007/978-1-0716-3287-1_11
M3 - Chapter
C2 - 37300772
AN - SCOPUS:85163613679
T3 - Methods in Molecular Biology
SP - 135
EP - 151
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -